Why it matters: The study highlights the widespread use of hemp-derived cannabinoids, such as CBD and delta-8 THC, in the US. It also suggests that states that prohibit cannabis may inadvertently promote the use of delta-8 THC due to its legal availability. The lack of regulation for hemp products raises concerns about the safety and quality of these products.
What they are saying: The study reveals that 25.2% of adults in the US reported using hemp-derived cannabinoids in the past year, with CBD being the most commonly used. The researchers emphasize the need for ongoing surveillance of emerging cannabinoids due to the lack of industry standards and potential risks associated with their use. The study also mentions that hemp products, including delta-8 THC, can be psychoactive.
The big picture: The legalization of hemp cultivation and sale through the 2018 Farm Bill has led to the availability of hemp-derived products in various retail outlets. However, the lack of regulation by the FDA means that there are no federal standards for testing the safety and accuracy of ingredients in these products. This poses potential risks to consumers, such as exposure to contaminants and unknowingly consuming products without the active ingredient.
What to watch: It will be important to monitor the ongoing public health surveillance efforts focused on emerging cannabinoids. Future research should aim to understand the perceptions of safety, motivations for use, and outcomes associated with these products. Regulatory measures may be necessary to ensure the safety and quality of hemp-derived cannabinoids.
My take: The study highlights the widespread use of hemp-derived cannabinoids in the US and raises concerns about the lack of regulation and potential risks associated with these products. It is crucial to prioritize consumer safety by establishing industry standards and implementing regulatory measures. Further research is needed to better understand the effects and risks of hemp-derived cannabinoids and to inform public health guidance and policies.
